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Abstract
Differentiation of T helper 17 cells (Th17) is a multistep process that involves the cytokines IL-6, TGF-b, and IL-23 as well as
IL-1b, IL-21, and TNF-a. Thereby, robust induction of the capacity to produce IL-17 involves epigenetic modifications of the
syntenic Il17a/f locus. Using inbred mouse strains, we identified co-regulation of gene transcription at the Il17a/f locus with
the nearby microRNAs miR-133b and miR-206 that are clustered approximately 45 kb upstream of Il17a/f. Expression of
these microRNAs was specific for Th17 as compared to other CD4
+ T cell subsets and this was equally valid for in vitro
polarized and ex vivo derived cells. From all factors analyzed, IL-23 was the most important cytokine for the in vitro induction
of miR-133b and miR-206 in naive CD4
+ T cells of wild type mice. However, analysis of IL-23R deficient mice revealed that IL-
23R signaling was not essential for the induction of miR-133b and miR-206. Importantly, we found a similar co-regulation in
CCR6
+ and other cd T cell subsets that are predisposed to production of IL-17. Taken together, we discovered a novel
feature of T cell differentiation towards an IL-17-producing phenotype that is shared between ab and cd T cells. Notably, the
specific co-regulation of miR-133b and miR-206 with the Il17a/f locus also extended to human Th17 cells. This qualifies
expression of miR-133b and miR-206 in T cells as novel biomarkers for Th17-type immune reactions.
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Introduction
microRNAs (miRNAs) are 21–24 nucleotide long non-coding
RNAs which play a critical role in the regulation of gene
expression. They usually target the 39 untranslated region (39-
UTR) of their respective target gene(s) at the mRNA level –
resulting in mRNA degradation, mRNA destabilization or
inhibition of translation [1].
Gene regulation by miRNAs has recently emerged to be critical
for both development and proper function of the immune system.
Thus, various miRNAs such as miR-155, miR-223, miR-146,
miR-150, miR-181a or the miR-17,92 cluster have been
implicated in hematopoietic lineage decisions or in controlling
different developmental checkpoints [2,3]. Furthermore, miRNAs
contribute to the terminal differentiation of mature lymphocytes
[4,5,6].
CD4
+ T helper (Th) cells orchestrate the adaptive immune
response so that appropriate effector mechanisms are elicited
dependent on the nature of the invading pathogen. Th1 cells are
induced to produce mainly IFN-c in order to fight viruses and
intracellular bacteria, whereas Th2 cells produce IL-4/-5/-13 in
response to infections by helminths and other parasites. More
recently, Th17 cells have been described to secrete IL-17A, IL-17F
and IL-22 to combat extracellular bacteria and fungi by
stimulating epithelial cells to produce chemokines and cytokines,
which drive the immune response e.g. by neutrophil influx [7,8].
Finally, CD4
+ T cell differentiation can also lead to the
development of tolerogenic induced regulatory T cells (iTreg).
Dysregulation of Th cell differentiation may result in ineffective
clearance of pathogens and/or in the development of autoimmune
or allergic diseases. Therefore, Th cell differentiation needs to be
tightly regulated. In this context, miRNAs have been shown to be
involved in the development or function of all four main T helper
subsets [9,10], i.e. miR-155 in Th1, miR-126 in Th2, miR-155 in
Treg and miR-326 in Th17. For instance, deletion of a single
miRNA, miR-155, can influence the fitness of Treg cells [11].
Furthermore, Ets-1, a negative regulator of Th17 differentiation,
has been recently reported as a target of miR-326, the amount of
which seems to be associated with disease relapse in multiple
sclerosis patients [12]. However, these authors did not directly
correlate the production of IL-17A, the key cytokine of Th17 cells,
with disease onset and severity.
In addition to CD4
+ Th17 cells, cd T cells are major or even
main producers of IL-17A depending on the physiological or
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e20171pathological context [13]. Recently, we and others identified a
subset of cd T cells expressing the CC chemokine receptor (CCR)
6 as potent IL-17A producers upon cytokine stimulation,
encounter with pathogen products or environmental cues [14,15].
Genome-wide gene expression analysis has recently revealed
that eukaryotic gene regulation is not only dependent on the direct
action of transcription factors on promoter regions, but is also
subject to higher order regulation dependent on the location of
genes within the genome [16]. Thus, co-expression of genes
depends in part on their relative distance with neighboring genes
being frequently co-expressed [17], either because of shared
regulatory elements or because of extended chromatin opening.
Likewise, the gene for two miRNAs miR-133b and miR-206,
which are probably expressed from a bicistronic pri-miRNA [18],
is located directly upstream of the Il17a and Il17f (Il17a/f) gene
locus. So far, miR-206 and miR-133b have been reported to be
specifically important for muscle regeneration and development
[18,19,20] and their expression has been suggested to be largely
restricted to skeletal muscle and osteoblasts. However, based on
their close proximity to the Il17a/f gene locus we hypothesized
that expression of these two miRNAs and secretion of the main
Th17 cytokine IL-17A might correlate. Here, we demonstrate
elevated expression of miR-206/133b in in vitro polarized Th17
cells as well as in freshly isolated murine and human Th17 cells
and in IL-17A producing innate lymphocytes such as CCR6-
expressing cd T cells. Furthermore, we show that amongst
multiple Th17 polarizing cytokines, IL-23 was the most important
one for miR-133b and miR-206 expression. Taken together, our
data reveal a previously unrecognized expression of miR-206/
133b in lymphocytes, which is tightly coordinated with the
expression of IL-17A.
Results
miRNAs miR-133b and miR-206 are syntenic to the Il17a/f
locus and are specifically expressed in Th17 cells
polarized in vitro
Many miRNAs have been found to be clustered and are likely to
be co-expressed when less than 50 kb apart [21]. miR-133b and
miR-206 form such a cluster with a distance of approximately 4 kb
between the coding sequences of the two mature miRNAs. We
found that in the murine genome the miR-206/133b cluster lies in
close proximity (less than 50 kb upstream) to the genes coding for
the cytokines IL-17A and IL-17F (Fig. 1A), which themselves are
organized syntenically in a head-to-head direction and probably
arose through gene duplication.
The miR-206/133b cluster is present in all vertebrate genomes
analyzed so far [22]. Performing whole genome alignment using
VISTA [23] we tested whether the proximity of miR-206/133b to
the Il17a/f locus is similarly conserved. This analysis revealed that
indeed miR-206/133b is syntenic to the Il17a/f locus in mouse
and humans (Fig. 1B) as well as in rat and chimpanzee (data not
shown). Furthermore, the mature miRNA sequences of miR-133b
and miR-206 are identical between mouse, human, rat and
chimpanzee (Fig. 1C).
Genome-wide expression analysis has revealed that neighboring
genes are frequently co-expressed [17] suggesting that the miR-
206/133b cluster and IL-17A/F might be co-expressed as well. To
test this hypothesis, we isolated CD4
+ T cells from transgenic mice
expressing the DO11.10 T cell receptor specific for ovalbumin
(amino acids 323–339). Cells were stimulated under neutral
conditions (Th0) or polarized in vitro towards the Th1, Th2, Th17
and Treg lineages. Expression of miR-133b and miR-206 was
assessed using qRT-PCR. Polarization towards Th17 resulted in a
13-fold increase of miR-133b expression when compared to Th0
cells, whereas polarization into other CD4
+ T cell lineages did not
alter miR-133b expression (Fig. 1D). Similarly, elevated miR-206
expression (78-fold relative to Th0) was only detected in Th17, but
not in Th1, Th2 or Treg polarized cells (Fig. 1E). However,
additional stimulation of Th17-polarized cells with PMA/
ionomycin did not influence the expression of miR-133b and
miR-206 (Fig. S1). Together, these results indicate that the two
miRNAs of the miR-206/133b cluster are indeed co-regulated
together and with the neighboring IL-17 locus.
Th17 cells express elevated amounts of miR-133b and
miR-206 in vivo
Although in vitro polarization recapitulates the phenotypes of
various Th lineages, in vitro and in vivo polarized cells may not
necessarily be identical. Therefore, we assessed miR-133b and
miR-206 expression levels in freshly isolated T cells. To this end,
CD4
+ T cells were sorted ex vivo based on IL-17A expression as
assessed using an IL-17A secretion assay (Fig. 2A, right panels).
Consistent with data obtained from in vitro polarized cells, IL-17A
secreting cells expressed 16-fold higher levels of miR-133b and 26-
fold higher levels of miR-206 when compared to IL-17A negative
CD4
+ T cells (Fig. 2A, left panel). Since miR-133b and, especially,
miR-206 are important for muscle cell proliferation and
differentiation [24], we sought to exclude the possibility that cell
activation and proliferation correlated with heightened expression
of these miRNAs. However, when comparing their expression in
sorted activated/memory CD4
+ T cells versus naive CD4
+ T cells
we found only a marginal upregulation of miR-206/133b in the
former (,2 fold), which may reflect the few Th17 cells contained
in the activated/memory CD4
+ T cell population (Fig. S2).
Furthermore, RORct has been described as signature transcrip-
tion factor for Th17 cells. Therefore, we extended our analyses of
miR-206/133b expression to CD4
+ T cells positive or negative for
RORct expression as assessed by expression of a GFP reporter
gene knocked into the Rorc locus [25]. Low levels of GFP
fluorescence intensity precluded the isolation of pure GFP-positive
and GFP-negative populations (Fig. 2B, right panels). Neverthe-
less, both miR-133b and miR-206 expression was elevated 7-fold
and 8-fold, respectively, in cells enriched for RORct (GFP)
expression when compared to RORct (GFP)-negative cells (Fig. 2B
left panel). Thus, in CD4
+ T cells miR-133b and miR-206 are co-
expressed with IL-17A in vivo.
Co-expression of IL-17A and miR-206/133b in cd T cells
Recently, evidence has emerged that innate lymphocytes such
as cd T cells constitute a major source of IL-17A [13,26]. We and
others have shown that IL-17A production in cd T cells is largely
restricted to a CC chemokine receptor (CCR) 6 expressing
subpopulation [14,15]. It was thus instrumental to test whether co-
expression of miR-133b and miR-206 is restricted to CD4
+ Th17
cells or whether it is a more general phenomenon. To this end, we
isolated cd T cells based on reporter gene expression from C57BL/
6-Tcrd-H2BeGFP mice [27], in which all cd T cells express high
levels of GFP, and separated these cells into CCR6-positive and
CCR6-negative subsets (Fig. 3A, right panels). qRT-PCR revealed
that CCR6-positive cd T cells expressed 15-fold and 21-fold
higher levels of miR-133b and miR-206, respectively, when
compared to CCR6-negative cd T cells (Fig. 3A, left panel).
Expression of RORct is not only indicative of CD4
+ Th17 cells,
but also characterizes cd T cells expressing IL-17A [26].
Therefore, we isolated GFP-positive and GFP-negative cd T cells
from RORct reporter mice as described for Figure 2B (Fig. 3B,
right panels) and assessed the expression of miR-133b and miR-
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positive cells when compared to GFP-negative cells (both
approximately 8-fold). Another marker used to distinguish subsets
of cd T cells is CD27, and CD27 expression inversely correlates
with the expression of IL-17A [28]. Thus, CD27 expression might
serve as an additional tool to assess the correlation between miR-
206/133b expression and IL-17A expression. CD27-positive and
CD27-negative cd T cells were sorted from Tcrd-H2BeGFP
reporter mice (Fig. 3C, right panels) and expression levels of
miR-133b and miR-206 were assessed by qRT-PCR. In
accordance with a less stringent correlation of CD27 expression
and IL-17A expression, expression levels of miR-133b and miR-
206 were only slightly elevated (2-fold and 2.5-fold, respectively) in
CD27-negative versus CD27-positive cd T cells (Fig. 3C, left
panel). Taken together, these data indicate that co-expression of
miR-206/133b and IL-17A is not restricted to CD4
+ Th17 cells,
but also holds true for IL-17A expressing innate lymphocytes,
suggesting that this co-regulation is a general phenomenon shared
between ab and cd T cells.
IL-23 promotes expression of miR-206/133b
Th17 cell polarization can be induced in vitro using a
combination of various cytokines such as IL-23, TGF-b, IL-6
and IL-1b. Whereas IL-6 and low amounts of TGF-b are
necessary to differentiate naive CD4
+ T cells into Th17 cells, IL-23
appears to be essential for sustained differentiation of Th17 cells
[29]. However, the extent of IL-17 induction by individual
cytokines may vary and thus comparing induction of IL-17 with
induction of miR-206/133b by individual Th17 polarizing
cytokines might provide some mechanistic insight into miR-206/
133b/IL-17 co-regulation. Therefore, DO11.10 TCR transgenic
CD4
+ T cells were polarized towards Th17 using individual
polarizing cytokines as well as cytokine combinations. Notably,
under these conditions, addition of IL-23 alone was able to induce
low levels of miR-133b and miR-206 (Fig. 4A, B) as well as IL-17A
as assessed by ELISA (Fig. 4C). Furthermore, combination of two
cytokines induced marked up-regulation of the two miRNAs and
IL-17A secretion only when IL-23 was part of the combination
and no additive effect was observed, when two other cytokines
were applied. Thus, of all cytokines tested IL-23 appears to be the
most important for expression of miR-133b and miR-206 under
standard conditions of in vitro polarization. Since in these
experiments IL-4 and IFN-c but not TGF-b or other factors were
blocked it is likely that traces of IL-23R inducing cytokines were
derived from fetal bovine serum in the medium. This is consistent
with the observation that combination of all four cytokines
generally used for Th17 polarization, namely IL-23, TGF-b, IL-6
and IL-1b or the additional use of IL-21 and TNF-a resulted in a
profound synergistic effect with respect to miR-133b and miR-206
upregulation when compared to IL-23 alone or a combination of
two cytokines (Fig. 4A, B). IL-17A levels of secretion appeared to
follow the same pattern (Fig. 4C). In order to more quantitatively
assess the correlation between induction of miR-133b and miR-
206 versus secretion of IL-17A dependent on the different cytokine
cocktails used for polarization, we determined the respective
correlation coefficients. Both miR-133b induction (Fig. 4D) as well
as miR-206 induction (Fig. 4E) correlated strongly with secretion
of IL-17A with correlation coefficients R
2 of 0.97 and 0.95,
respectively. Taken together, these results point to an important
role of IL-23 signaling in miR-206/133b induction in lymphocytes
and strengthen the hypothesis of a strict co-regulation of miR-
206/133b and IL-17A. However, truly naive CD4
+ T cells do not
Figure 1. miRNAs miR-133b and miR-206 are syntenic to the IL-17A/IL-17F locus and are specifically expressed in Th17 cells
polarized in vitro. (A) Schematic representation of the Il17a/f locus. Il17a and Il17f are syntenically linked in approx. 44 kB distance. The two miRNAs
miR-133b and miR-206 are located in close proximity upstream to the Il17a/f locus. (B) VISTA plot of the mouse Il17a/f locus in which mouse sequence
is shown on the x axis and percent similarity to human on the y axis. (C) Sequence comparison of mature miR-133b and miR-206 in H.s., M.m. R.n. and
P.t. (D), (E) Spleen and peripheral lymph node cells were isolated from DO11.10 mice, co-cultured with sex-matched BALB/c irradiated feeder cells and
polarized for the different T helper cell subset conditions (Th0, Th1, Th2, Th17 and Treg). Expression levels of miR-133b (D) and miR-206 (E) were
analyzed by qRT-PCR. Values are plotted as fold difference compared to non-polarized cells (Th0). Error bars show 6SEM of n$3 experiments with 2–3
mice per experiment.
doi:10.1371/journal.pone.0020171.g001
Figure 2. IL-17 producing in vivo polarized CD4
+ Th17 cells
express elevated amounts of miR-133b and miR-206. (A) CD4
+ T
cells from C57BL/6 mice were sorted into IL-17A
+ and IL-17A
2
populations and analyzed for expression of miR-133b and miR-206 by
qRT-PCR. Dot plots show post-sort analysis of one representative
experiment. (B) CD4
+ T cells were sorted into GFP
+ (Rorct
+) and GFP
2
(Rorct
2) populations from heterozygous Rorct reporter mice and
analyzed as in (A). Dot plots show post-sort analysis of one
representative experiment. Values are plotted as fold increase (=ratio)
compared to the respective negative population. The graphs show
representative experiments from n=3 independent experiments with
similar results. Error bars represent SD values of triplicates from one
experiment with 4–6 mice.
doi:10.1371/journal.pone.0020171.g002
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expression of miR-206/133b as well as secretion of IL-17A. (A,
B) Spleen and peripheral lymph node cells were isolated from DO11.10
mice, cocultered with sex-matched BALB/c irradiated feeder cells and
polarized to either Th1 or treated with TGF-b, IL-6, IL-23, IL-1b, IL-21 and
TNF-a in various combinations (4cytokines=TGF-b, IL-6, IL-23 and IL-
1b). Values show fold increase (=ratio) compared to cells cultured only
with Ova323–329/antibodies. Expression levels of miR-133b (A) and miR-
206 (B) were analyzed by qRT-PCR. (C) Secreted IL-17A was determined
in culture supernatants of each condition from the cells in (A) and (B) by
ELISA. Values show absolute amounts of IL-17A in the cell culture
supernatant in ng/ml. Error bars show 6SEM of n=3 experiments with
2–3 mice per experiment. (D), (E) Scatter plot of IL-17A protein
concentration versus relative expression of miR-133b (D) and miR-206
(E) and correlation coefficient for ELISA compared to qRT-PCR.
doi:10.1371/journal.pone.0020171.g004
Figure 3. Correlation of IL-17A production and miR-206/133b
expression in cd T cells. (A) cd T cells from Tcrd-H2BeGFP mice were
sorted into a CCR6
+ and CCR6
2 populations and analyzed for
expression of miR-133b and miR-206 by qRT-PCR. Dot plots show
post-sort analysis of one representative experiment. (B) cd T cells were
sorted into GFP
+ (Rorct
+)a n dG F P
2 (Rorct
2) populations from
heterozygous Rorct reporter mice and analyzed as in (A). (C) cd T cells
from Tcrd-H2BeGFP mice were sorted into CD27
2 and CD27
+
populations and analyzed as in (A). Dot plots show post-sort analysis
of one representative experiment. Values are plotted as fold increase
(=ratio) compared to the respective negative population. The graphs
show representative experiments from n=3 independent experiments
with similar results. Error bars represent SD values of triplicates from
one experiment with 4–6 mice.
doi:10.1371/journal.pone.0020171.g003
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induction of miR-206/133b in vivo we sorted ab or cd T cells from
either heterozygous or homozygous IL-23R-GFP knock-out/
reporter-knock-in mice [30]. We found that IL-23R expression
was not required for miR-206/133b expression in IL-23R-
reporter GFP
+ cells (Fig. 5). We thus propose that IL-23 chiefly
promotes the expansion and maintenance of IL-17 producing
cells.
Primary human Th17 cells, but not Th1 cells, express miR-
133b and miR-206
Human Th17 cells have been suggested to be involved in
diseases such as multiple sclerosis [31] or juvenile idiopathic
arthritis [32], but have been described to differ in certain aspects
from their murine counterparts, e.g. human Th17 cells co-express
IFN-c more often than murine Th17 cells [33]. Given these
apparent differences, we tested whether miR-206/133b and IL-17
were co-regulated in human Th17 cells as well. Therefore, we
isolated human primary Th17, Th1 and Th0 cells from healthy
donors using a combination of IL-17 and IFN-c cytokine secretion
assays as described [34]. Although a certain degree of donor
variability was observed, expression levels of miR-133b and miR-
206 were consistently higher in IL-17A secreting human T cells (2
to 4-fold and 15 to 60-fold, respectively) when compared to Th0
cells (Fig. 6). In contrast, miR-206/133b levels were largely
identical between human Th1 and Th0 cells. Thus, our data
indicate that the miR-206/133b cluster is co-regulated with IL-17
in human T cells as well. In conclusion, we provide evidence that
the two miRNAs of the miR-206/133b cluster neighboring the
Il17a/f locus are co-regulated in murine and human lymphocytes.
Little impact of ectopic miR-206/133b expression on
Th17 differentiation
Finally, to examine a potential functional role of the miR-206/
133b cluster in Th17 polarization, we undertook a series of efforts
to manipulate the expression of the two investigated miRNAs in T
cells both in vivo and in vitro. To this end, we employed retroviral
vectors for miRNAs miR-133b and miR-206 based on MDH1-
PGK-GFP_2.0 [35]. The respective constructs were used for stable
transduction of ovalbumin-specific T cells from DO11.10 mice
that were previously stimulated with their cognate OVA-peptide
for 24 h under non-polarizing conditions. After transduction, T
cells were cultured under Th17 or other conditions for an
additional 7 days. After restimulation with PMA/ionomycin, cells
were fixed and stained for intracellular IL-17. IL-17 producing
cells were equally frequent among transduced GFP
+ and non-
transduced GFP
2 DO11.10 cells (Fig. 7A). Furthermore, to test a
potential role of miR-133b and miR-206 in the development of IL-
17 producing cells in vivo, we retrovirally transduced bone marrow
Figure 5. IL-23R signalling is not essential for the induction of
miR-133b and mir-206. IL-23R
+ (GFP
+) or IL-23R
2 (GFP
2) cd and ab T
cells from either homozygous (IL-23R
2/2) or heterozygous IL-23Rgfp.KI
mice were compared for their miR-133b and miR-206 expression in (A)
and (B). GFP
+ cd and ab T cells from heterozygous or GFP
+ cd and ab T
cells from homozygous IL-23Rgfp.KI mice were compared for their miR-
133b and miR-206 expression in (C) and (D). Error bars show 6SEM of
n=3 experiments with cells pooled from 10 mice per group.
doi:10.1371/journal.pone.0020171.g005
Figure 6. Primary human Th17 cells, but not Th1 cells, express
miR-133b and miR-206. CD4
+ T cells were isolated from peripheral
blood of 3 human healthy donors, enriched using magnetic beads and
then FACS sorted into 3 different populations: IL-17A
+, IL-17A
2 IFNc
+
and IL-17A
2IFN-c
2. Expression levels of miR-133b and miR-206 were
analyzed by qRT-PCR. Values are plotted as fold increase compared to
the respective IL-17A
2 IFN-c
2 population. P-value for miR-206 in
IL-17A
+ compared to IFN-c
+ expressing cells was 0.0645. Error bars show
6SEM for the 3 different donors.
doi:10.1371/journal.pone.0020171.g006
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PLoS ONE | www.plosone.org 6 May 2011 | Volume 6 | Issue 5 | e20171Figure 7. Functional outcome of ectopically expressed miR-133b and miR-206 in vitro and in vivo. (A) In vitro assay. MACS-enriched CD4
+
T cells from TCR-transgenic DO.11.10 mice were retrovirally transduced with miR-133b or miR-206 or with both and stimulated under Th17
polarization inducing conditions. Frequency of IL-17 producing CD4
+ T cells among transduced (GFP
+) and non-transduced (GFP
2) cells of the same
well was compared. One representative of two independent experiments with similar results is shown. (B, C) Frequency of IL-17 producing cells
overexpressing miR-133b or miR-206 in vivo. Lineage negative bone marrow was transduced with miR-133b or miR-206 or with the empty vector
MDH1-PGK-GFP2.0 and served to reconstitute lethally irradiated C57BL/6 wild type mice. After 8–10 weeks, chimeras were analyzed for the occurrence
and frequency of IL-17 producing cells within the transduced GFP
+ and non-transduced GFP
2 lymphocytes from peripheral lymph nodes and spleen.
(B) Representative gating strategy after excluding autofluorescent and B220
+ cells. (C) Frequency of IL-17 producing CD4
+ and CD4
2 cells,
respectively. At least 5 chimeric mice were individually analyzed for each condition.
doi:10.1371/journal.pone.0020171.g007
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chimeras that contained transduced GFP
+ and non-transduced
GFP
2 T cells. Although statistically not significant, we observed a
trend pointing to a higher frequency of IL-17 producing cells
among the CD4
+ Th and CD4
2 cells in chimeras from bone
marrow transduced with either miR-133b or miR-206 but not the
empty vector (Fig. 7B, C).
Discussion
In this work, we revealed a tight co-regulation of the
expression of the miR-206/133b cluster with the potential to
produce the pro-inflammatory cytokine IL-17A in lymphocytes.
This finding was equally valid for cells that had acquired the
capacity to produce IL-17 cytokines in vivo and for in vitro
polarized CD4
+ Th17 cells. Furthermore, this co-regulation was
similarly observed in those subsets of cd T cells that were
reported to be genuine IL-17A producers, i.e. characterized by
the expression of CCR6 [14,15] and the IL-23R [36]. However,
at present it is not clear whether expression of miR-206/133b
plays a functional role in Th17 lineage differentiation by
targeting specific mRNAs or whether its expression may just
be involved in epigenetic regulation of the Il17a/f locus. In fact,
experiments, in which miR-206 or miR-133b or both were over-
expressed in T cells showed no significant changes in the
capacity of naive ab T cells to become polarized towards Th17
or other Th lineages as well as iTreg. Similarly, over-expression
of miR-206 or miR-133b in bone marrow chimeras did not
reveal striking changes in the frequency of IL-17 producing
CD4
+ Th or CD4
2 cells.
Synteny of the miR-206/133b and Il17a/f loci is conserved
among mammals and chicken, suggesting that the transcriptional
co-regulation is physiologically relevant. Along this line, genome-
wide gene expression studies suggest that neighboring co-expressed
genes in eukaryotes are often functionally connected, implying
some operational similarity to prokaryotic operons [16]. However,
despite the high expression levels of miR-206/133b we found no
detectable expression of Il17 in muscle tissue (Fig. S3) suggesting
that the co-regulation of the miR-206/133b cluster and the Il17a/f
locus is specific for T lymphocytes.
Recently, Akimzhanov et al. characterized the size of the locus
control region of the Il17a/f genes, which extends beyond the
highly conserved non-coding sequences upstream of the Il17a/f
locus, where miR-206/133b is located [37]. Furthermore, miR-
206/133b are close to a conserved noncoding sequence (CNS-1 or
-60 region), which was recently reported to undergo chromatin
remodeling in Th17 cell differentiation and therefore possibly
provides accessibility to regulatory elements [38]. In addition to
classical roles of miRNAs, namely gene-regulation by targeting 39-
UTRs of mRNA, it is thus conceivable that expression of the
miRNAs miR-133b and miR-206 is involved in the regulation of
Il17a and Il17f locus accessibility comparable to the involvement
of miRNA in DNA methylation in plants [39]. Transcriptional
activity of the miR-206/133b cluster may promote opening of the
whole region including the Il17a/f locus. Likewise, the miR-181-
a1/181-b1 cluster is located upstream of the CD45 gene locus and
is known to be involved in the T versus B lineage decision in
CD45
+ lymphocytes [35].
Using quantitative Real-Time PCR (qRT-PCR), we found
considerable differences of miR-206/133b expression levels
between IL-17 producing and non-producing cells suggesting
high specificity of the assay. Indeed, a very recent comprehensive
resource study based on deep-sequencing reproduced our
findings that miR-206/133b are specifically upregulated in
Th17 cells compared to other T cell subsets [40]. However,
overall expression levels of miR-133b in lymphocytes were much
lower when compared to samples of skin and muscle tissue.
Notably, miR-206 was expressed to considerable extents in Th17
cells with more than 1000 sequence tags per million. Further-
more, expression of this miRNA was only 14-fold and 19-fold
lower in Th17 cells when compared to skin and muscle [40].
Accordingly, miR-206/133b were initially described to be
specifically expressed in skeletal muscle as well as osteoblasts
suggesting that the Il17a/f locus might be accessible for gene
transcription in these tissues as well. So far, expression of IL-17A
and/or IL-17F has not been reported for these cell types.
Whereas IL-17A expression is thought to be restricted to
lymphocytes, IL-17F expression has also been demonstrated in
colonic epithelial cells [41]. Several targets of miR-133b and
miR-206 such as DNA pol a, connexin43, histone deacetylase 4
(HDAC4) and the transcription factor Pitx3 have been reported
to play a role in muscle development, regeneration of neuro-
muscular synapses as well as osteoblast function [22,42,43,44].
Therefore, it will be interesting to see whether such targets are
also functionally regulated in IL-17A producing lymphocytes. In
addition, we performed in silico analysis of potential target genes
for both miRNAs with the target prediction tools miRANDA,
TargetScan and PicTar in order to identify novel target genes of
potential immunological interest. Interestingly, the gene coding
for the transcription factor Ets1 was predicted to be a target of
both miR-133b (one predicted recognition site) and miR-206
(four predicted recognition sites). Ets1 was previously suggested to
regulate Th17 cell differentiation as a direct target of miR-326
[12]. However, we could not confirm an effect of miR-133b or
miR-206 overexpression on constructs containing the 39-UTR of
the Ets1 gene in the context of the BW5147a-b-t h y m o m ac e l l
line (Fig. S4).
Co-regulation of neighboring genes may be controlled by
multiple non-mutually exclusive factors. Thus, changes in
chromatin status may occur over extended distances. Location of
miR-206/133b within the reported locus control region of the
Il17a/f gene is consistent with this hypothesis. Alternatively,
neighboring genes may directly share promoter or enhancer
elements. In this study we found that both miR-206/133b and IL-
17A can be induced by IL-23 signaling. IL-23/p19 induced
activation of STAT3 leads to direct binding of phosphorylated
STAT3 to IL-17A and IL-17F promoters suggesting that, in
addition to chromatin remodeling, sharing of regulatory elements
may as well contribute to co-regulation of miR-206/133b and IL-
17A [45]. Taken together, we discovered co-regulation of miR-
133b and miR-206 with the Il17a/f locus as a novel feature of T
cell differentiation that is shared between mouse ab and cd T cells
and also extended to human Th17 cells. This qualifies transcrip-
tion of miR-133b and miR-206 as a novel marker for T cells of an
IL-17-producing phenotype.
Materials and Methods
Mice
Six- to ten-wk-old C57BL/6N and B6.129P2(Cg)-Rorc
tm2Litt/J
[25], BALB/c DO11.10 TCR-transgenic mice were purchased
from either Charles River (Germany) or from The Jackson
Laboratory. C57BL/6-Tcrd-H2BeGFP mice have been described
before [27]. IL-23Rgfp.KI mice have been described previously
[30,46]. Mice were bred and housed under specific pathogen free
(SPF) conditions in individually ventilated cages (IVC) either at the
Hannover Medical School animal facility or at the SPF facility at
the Technical University Munich and all animal experiments were
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Niedersa ¨chsisches Landesamt fu ¨r Verbraucherschutz und Lebens-
mittelsicherheit or by the Bavarian state authorities (permit
number 33.9-42502-04-07/1253).
In vitro cytokine stimulation assays
CD4
+ T cells were isolated from mixed single cell suspensions of
spleen and peripheral lymph nodes by MACS cells separation with
the CD4
+ T Cell Isolation Kit (Miltenyi). CD4
+ cells from BALB/c
DO11.10 TCR transgenic mice were co-cultured for 6–7 days with
irradiated (30 Gy) spleen-derived and sex-matched BALB/c feeder
cells in a ratio of 1610
6 DO11.10 to 3610
6 BALB/c spleen cells per
ml. The mouse cytokines TGF-b (2 ng/ml), IL-6 (10 ng/ml), IL-1b
(10 ng/ml), IL-21 (10 ng/ml) and TNF-a (10 ng/ml) were
purchased from Peprotech. Ovalbumin peptide (Ova323–339,
5 mg/ml) was from Anaspec and IL-23 (10 ng/ml) (mouse) from
R&D Systems. Human rIL-2 was obtained through the AIDS
Research and Reference Reagent Program, Division of AIDS,
NIAID, NIH: from Dr. Maurice Gately, Hoffmann – La Roche.
For the Th0 condition IL-2 (300 IU/ml) and Ova322–339 were
added to the co-cultured cells. The Th17 mix contained TGF-b,I L -
6, IL-23, IL-1b, TNF-a, anti-IL-4, anti-IFN-c and Ova323–339. The
Treg cytokine mix was as follows: IL-2, TGF-b (10 ng/ml), RA
(5 nM) and Ova323–339. Th1 polarization mix: IL-2, IL-12 (10 ng/
ml, Peprotech), anti-IL-4 and Ova323–339. Th2 polarization mix: IL-
2, IL-4 (20 ng/ml, Peprotech), anti-IFN-c and Ova323–339.
Successful polarization was assessed by intracellular staining for
the key cytokines IFN-c, IL-4, IL-17 and the Treg signature
transcription factor FoxP3 (data not shown). Anti-IL-4 (clone
11B11, 10 mg/ml) [47] and anti-IFN-c (clone XMG1.2, 10 mg/ml)
[48] were produced in rat hybridoma cell lines, anti-IL-12 (p40/
p70, 10 mg/ml) was from BD Pharmingen. Retinoic acid (RA) was
obtained from Sigma-Aldrich.
For measurement of intracellular cytokines, T cells were re-
stimulated with 50 ng/ml Phorbol-12-myristate-13-acetate (PMA,
Calbiochem) and 2 mg/ml ionomycin (Invitrogen) in the presence
of brefeldin A (Sigma). Cells were fixed using the BD Cytofix/
Cytoperm Kit as described in the supplier’s manual.
The IL-17A Secretion Assay (Mouse) was carried out according
to the manufacturer’s instructions. Briefly, single cell suspensions
of spleens and peripheral lymph nodes of C57BL/6N mice were
stimulated with PMA/ionomycin (50 ng/ml/2 mg/ml) for 3 hours
at 37uC with 5% CO2. In the next step cells were labelled with the
IL-17 Catch Reagent, cultured under rotation at 37uC for 45 min,
labelled with the IL-17 Detection Antibody (Biotin) and finally
labelled with Anti-Biotin-PE and anti-CD4 (GK1.5) antibody in
the presence of FcR block (2.4G2).
Ex vivo FACS cells sorting and FACS analysis
Antibodies directed against abTCR (clone H57-597), CD4
(clone GK1.5), B220 (clone RA3-GB2), IL-17A (clone ebio17B7),
and CCR6 (anti-CD196,) were purchased from ebioscience.
Antibodies against CD8a (clone 53-6.7) and CD27 (clone
LG.3A10) were obtained from BD Pharmingen. Anti-TCRcd
(clone GL3), CD3 (clone 17A2) and anti-FcR antibody (clone
2.4G2) were produced in rat hybridoma cell lines. FACS analysis
was performed using an LSRII flow cytometer (BD Biosciences)
and data were collected with BD FACSDiva software (BD
Biosciences). FACS sorting was carried out in the central cell
sorting facility of the Hannover Medical School on a FACSAriaIIu
(BD) or on a MoFlow XDP (Beckman Coulter). Post acquisition
analyses and compensation were conducted using FlowJo software
8.8.7 (Treestar). IL-17 producing and non-producing CD4
+ ab T
cells were sorted from mixed spleen and peripheral lymph node
cells from C57BL/6N mice after revealing IL-17 secreting cells
using the mouse IL-17A Secretion Assay (Miltenyi) and subsequent
FACS-sorting. cd T cells [14] were sorted from mixed spleen and
peripheral lymph node cells from C57BL/6-Tcrd-H2BeGFP mice
based on eGFP and CCR6 expression. Rorct positive and negative
cells were sorted from mixed spleen and peripheral lymph node
cells from heterozygous B6.129P2(Cg)-Rorc
tm2Litt/J mice based on
their GFP expression. IL-23R expressing or non-expressing cells
were sorted according to their GFP expression from either
homozygous (=IL-23R
2/2) or heterozygous IL-23Rgfp.KI mice.
Human samples were sorted as follows: To capture cytokine
expressing cells, PBMC were enriched for CD4
+ T cells using
negative selection magnetic beads (Stemcell technologies) and
stimulated for 2 hours with PMA (10 ng/ml, Sigma) and
ionomycin (1 mg/ml, Sigma). IL-17A and IFN-c secreting cells
were detected by a human Secretion Assay, Miltenyi Biotec,
according to manufacturer’s instructions and co-stained for CD4
(CD4-PC7, Beckman Coulter).
Quantitative Real-Time PCR (qRT-PCR)
In vitro cultured or FACS sorted cells were resuspended in 700 ml
QIAzol lysis buffer, if not described differently and total RNA with
conservation of small RNAs was isolated by QIAgen miRNeasy Kit.
Quantitative Real-Time PCR was carried out using probes for hsa-
miR-133b or hsa-miR-206 (Applied Biosystems, Taqman miRNA
Assays ID 00510 and ID 002247) on an Applied Biosystems
StepOnePlus Real-TimePCR System.The validity of the qRT-PCR
assays for miR-133b and miR-206 was assessed by overexpression
and subsequent detection of these in BWa
2b
2 cells (Fig. S5). Fold-
difference was calculated by the DDCt method normalized to
snoRNA412 as housekeeping gene for mouse samples or RNU48 for
human samples (both Applied Biosystems Assay ID 001243 and ID
001006). The SD values for the representative experiments were
calculated from either triplicates or quadruplicates of the combined
coefficients of variation from sample and calibrator according to the
manufacturer’s manual (Applied Biosystems).
ELISA
Secreted IL-17A protein was detected by standard sandwich
ELISA purchased from BioLegend. Concentrations of IL-17A
were calculated using recombinant purified IL-17A protein.
Standard curve and sample concentrations were calculated based
on the mean of triplicates for each dilution or sample.
Retroviral infections
The retroviral constructs encoding mmu-miR-133b and mmu-
miR-206 were generated by inserting the respective pre-miRNA
sequences flanked by approximately 125 bp into the 39LTR of the
vector MDH-PGK1-GFP_2.0 (Addgene, [35]). miRNA sequences
were obtained by PCR from the BAC AC159614 with the
following primers:
206-forward: CCGGTTAACTCGAGGATAGTTTCTGG-
GAGTGTAG;
206-reverse: CTAGCTAGGAATTCGGAGAAGTCTGTA-
GAGGTAG;
133b-forward: CCGGTTAACTCGAGCTCTGTGAGAG-
GTTAGTCAG;
133b-reverse: CTAGCTAGGAATTCTGTGACCTGTGA-
ACTTGGGC.
The resulting vectors encode GFP under control of the PGK
promoter and miRNA under control of the human H1 promoter.
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of 293T cells with these retroviral constructs and the pCLEco
packaging plasmid (Imgenex). Lineage negative BM cells were
retrovirally transduced as described [49] and intravenously
injected into irradiated (9 Gy) syngeneic hosts. The resultant
chimeric mice were analyzed after 8–10 weeks. BW5147a-b-
thymoma cells or CD4
+ T cells from DO11.10-TCR transgenic
mice were transduced using standard spin infection and success-
fully transduced cells were identified based on GFP expression.
Statistics
Statistical analysis was performed using GraphPad Prism
software using the two-tailed unpaired Student’s t-test. P-
values,0.05 were considered as significant (*), ,0.01 (**),
,0.001 (***). If not otherwise described error bars are calculated
from SEM of n=3 experiments.
Supporting Information
Figure S1 Mitogenic stimulation of in vitro Th17
polarized cells does not change the expression level of
miR-133b or miR-206. Related to Figure 1D and 1E. The
same protocol as in Figure 1 was used for the polarization of T
cells to the Th17 lineage. 50% of the cells were additionally
stimulated with PMA/ionomycin for the last 3 h before harvesting.
Expression levels for miR-133b and miR-206 were compared by
qRT-PCR relative to Th0 (control). One representative experiment
is shown out of two independent experiments with similar results
with 2 mice per experiment. Error bars represent SD values.
(TIFF)
Figure S2 The activation status of CD4
+ T cells and cd T
cells does not influence miR-133b and miR-206 expres-
sion. Related to Figure 2 and Figure 3. (A) CD4
+ cells were
sorted into naive CD4
+ T cells (CD44
lo, CD62L
hi) and activated/
memory CD4
+ T cells (CD44
hi CD62L
lo) from lymph node and
spleen cells of C57BL/6N mice and compared for their expression
levels of miR-133b and miR-206 as described. Shown is one
experiment with 5 mice. (B) and (C) cd T cells were sorted into
CCR6
+, CCR6
2 CD44
hi and CCR6
2 CD44
lo cells from lymph
node and spleen cells of TcrdH2BeGFP mice and compared for
their expression levels of miR-133b and miR-206. Shown is one
representative experiment of two independent experiments with
similar results with 4–6 mice per experiment. Error bars show SD
values of 3 replicates.
(TIFF)
Figure S3 Expression of Il17a mRNA in skeletal muscle
compared to peripheral lymph node cells and Th17
polarized cells. Skeletal muscle (tibia), peripheral lymph node
(inguinal) and Th17 polarized cells were compared for their Il17a
mRNA expression by Taqman Real-Time PCR. Shown are the
results of 2 independent experiments from 1 mouse per group.
(TIFF)
Figure S4 No regulation of the predicted target gene
Ets1 by miR-133b or miR-206. Luciferase assay using the
psiCHECK-2 vector (Promega) into which the Ets1 39-UTR was
cloned downstream of Renilla luciferase. By nucleofection with the
Amaxa-nucleofection reagent the psiCHECK-2-Ets1 vector was
introduced into the BW5147 a-b- cell line that was stably
transduced with either the empty MDH1-PGK-GFP2.0 (Addgene)
plasmid, the latter plasmid with miR-133b or with miR-206.
(TIFF)
Figure S5 Proof of principle for the miRNA Real-Time
detection system. The miRNAs mmu-miR-133b and mmu-
miR-206 were cloned from the BAC AC159614 with the primers
mentioned in Materials and Methods. Both miRNAs were
introduced into the retroviral vector MDH1-PGK-GFP_2.0
(Addgene) with restriction enzymes EcoRI and XhoI. The respective
constructs were then transfected into 3T3 cells via Calcium-
Phosphate Transfection Kit (Sigma) and the supernatant was used
for the stable transfection of the BW5147a-b- thymoma cell line.
(TIFF)
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